Odonate Therapeutics Other Current Liabilities

Odonate Therapeutics (ODT) currently reports a other current liabilities of $18M as of September 2021. That compares with $15M in the prior-year period — up 23.3% year over year. Use the charts on this page to explore Odonate Therapeutics's other current liabilities history and peer comparisons.

Odonate Therapeutics's other current liabilities increased from $15M to $18M — a 23.3% year-over-year increase (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Odonate Therapeutics reported $18M in other current liabilities as of September 2021. That compares with $15M in the prior-year period — up 23.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $18M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Odonate Therapeutics, and consider following ODT for alerts when major investors trade the stock.

Odonate Therapeutics is classified in the Healthcare sector. On other current liabilities, it currently shows $18M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ODT with unrelated industries.